10/09/2026
HRT & Breast Cancer: What the 2002 WHI Study Really Tells Us
As we enter Breast Cancer Awareness Month, let’s look at what the 2002 Women’s Health Initiative (WHI) study found and what it means for women considering hormone replacement therapy (HRT) during menopause today. 💜
5 things to understand:
1️⃣ Not all hormones are the same.
The study tested specific medicines: estrogen and a synthetic progestin called MPA. It did not test every type of HRT.
2️⃣ Different hormones may have different risks.
Some HRT uses estradiol and micronized progesterone. These are different from the medicines studied, but that doesn’t mean they’re automatically safer.
3️⃣ Risk needs context.
In the estrogen-plus-progestin group, there were about 8 additional breast cancer cases per 10,000 women each year compared with placebo.
4️⃣ Estrogen alone had different results.
Among women who had their uterus removed, long-term follow-up found fewer breast cancer cases in the estrogen-only group.
5️⃣ Every woman’s situation is different.
Age, time since menopause, family history, genetics, and the type of hormones all matter when discussing HRT.
The big takeaway: One study can’t answer every woman’s question about HRT. What matters is understanding the research and weighing potential benefits and risks based on your individual health.
You deserve to understand your options and feel heard. If you have questions about HRT, menopause, or breast cancer risk, let’s start the conversation. 💜
